Key facts
- The Insides Company’s last known valuation is $80.5M (Sep 2021).
- It has raised $10.2M.
- Notable investors include Icehouse Ventures, K1W1, New Zealand Growth Capital Partners, Aspire NZ Seed Fund, Auckland UniServices — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for The Insides Company
- ·The full record, as it builds
Funding rounds
No funding rounds for The Insides Company are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About The Insides Company
Developer of medical devices designed to cure chronic and acute intestinal conditions in patients. The company's devices manage high-output Enteroatmospheric Fistulas and high-output Enterostomies without altering existing surgical procedures or the patient journey and care pathway, enabling patients to gain the benefits of restored bowel continuity.
- Sector
- Healthcare
- HQ
- Auckland, New Zealand
- Founded
- 2017
- Employees
- 17
- Website
- theinsides.co/
- Ownership
- Privately Held (backing)
The Insides Company doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in The Insides Company shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on The Insides Company in its N-PORT filings yet. We sweep new filings monthly.